Organizational Predictors and Use of Evidence-Based Practices in Adolescent Substance Abuse Treatment

Substance Abuse

Volumn 36, Issue 4, 2015, Pages 462-469

  Paino, Maria ^a   Aletraris, Lydia ^b   Roman, Paul M ^b  

^a OAKLAND UNIVERSITY   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Adolescent; evidence based practices; medication assisted treatment; substance abuse; treatment centers

Indexed keywords

ADOLESCENT; CHILD HEALTH CARE; DRUG DEPENDENCE TREATMENT; EVIDENCE BASED PRACTICE; HUMAN; NONBIOLOGICAL MODEL; ORGANIZATION AND MANAGEMENT; PROCEDURES; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS;

ADOLESCENT; ADOLESCENT HEALTH SERVICES; EVIDENCE-BASED PRACTICE; HUMANS; MODELS, ORGANIZATIONAL; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS;

EID: 84948080341     PISSN: 08897077     EISSN: 15470164     Source Type: Journal    
DOI: 10.1080/08897077.2014.960959     Document Type: Article

References (69)

1. Feinstein EC, Richter L, Foster SE. Commentary: addressing the critical health problem of adolescent substance use through health care, research, and public policy. J Adolesc Health. 2012; 50: 431-436.
2. National Center on Addiction Substance Abuse at Columbia University. Adolescent Substance Use: America's #1 Public Health Problem. New York: National Center on Addiction and Substance Abuse at Columbia University; 2011.
3. Substance Abuse and Mental Health Services Administration (SAMHSA). Results From the 2011 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2012.
4. Baggio S, N'Goran AA, Deline S, et al. Patterns of cannabis use and prospective associations with health issues among young males. Addiction. 2014; 109: 937-945.
5. McCambridge J, McAlaney J, Rowe R. Adult consequences of late adolescent alcohol consumption: a systematic review of cohort studies. PLoS Med. 2011; 8: 1-13.
6. Marshall EJ. Adolescent alcohol use: risks and consequences. Alcohol Alcohol. 2014; 49: 160-164.
7. Carney T, Myers B. Effectiveness of early interventions for substance-using adolescents: findings from a systematic review and meta-analysis. Subst Abuse Treat Prev Policy. 2012; 7: 1-15.
8. Dennis ML, Scott CK, Funk RR, Foss MA. The duration and correlates of addiction and treatment careers. J Subst Abuse Treat. 2005; 28: S51-S62.
9. Substance Abuse and Mental Health Services Administration (SAMHSA). Results From the 2012 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2013.
10. Battjes RJ, Gordon MS, O'Grady KE, Kinlock TW, Carswell MA. Factors that predict adolescent motivation for substance abuse treatment. J Subst Abuse Treat. 2003; 24: 221-232.
11. Broome KM, Joe GW, Simpson DD. Engagement models for adolescents in DATOS-A. J Adolesc Res. 2001; 16: 608-623.
12. Mensinger JL, Diamond GS, Kaminer Y, Wintersteen MB. Adolescent and Therapist perception of barriers to outpatient substance abuse treatment. Am J Addict. 2006; 15: 16-25.
13. Substance Abuse and Mental Health Services Administration (SAMHSA). The NSDUH Report: Substance Use Treatment Need Among Adolescents: 2003-2004. Rockville, MD: SAMHSA, Office of Applied Studies; 2006.
14. Godley MD, White WL. A brief history and some current dimensions of adolescent treatment in the United States. Recent Dev Alcohol. 2005; 17: 367-382.
15. Etheridge RM, Smith JC, Rounds-Bryant JL, Hubbard RL. Drug abuse treatment and comprehensive services for adolescents. J Adolesc Res. 2001; 16: 563-589.
16. Fishman MJ, Winstanley EL, Curran E, Garrett S, Subramaniam G. Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: preliminary case-series and feasibility. Addiction. 2010; 105: 1669-1676.
17. Castellanos-Ryan N, O'Leary-Barrett M, Conrod PJ. Substance-use in childhood and adolescence: a brief overview of developmental processes and their clinical implications. J Can Acad Child Adolesc Psychiatry. 2013; 22: 41-46.
18. Callaghan RC, Hathaway A, Cunningham JA, Vettese LC, Wyatt S, Taylor L. Does stage-of-change predict dropout in a culturally diverse sample of adolescents admitted to inpatient substance-abuse treatment A test of the Transtheoretical Model. Addict Behav. 2005; 30: 1834-1847.
19. Kaminer Y. Adolescent Substance Abuse: A Comprehensive Guide to Theory and Practice. New York: Plenum Press; 1994.
20. Ridenour TA, Cottler LB, Robins LN, Compton WM, Spitznagel EL, Cunningham-Williams RM. Test of the plausibility of adolescent substance use playing a causal role in developing adulthood antisocial behavior. J Abnorm Psychol. 2002; 111: 144-155.
21. Brannigan R, Schackman BR, Falco M, Millman RB. The quality of highly regarded adolescent substance abuse treatment programs. Arch Pediatr Adolesc Med. 2004; 158: 904-909.
22. Bracken BK, Rodolico J, Hill KP. Sex, age, and progression of drug use in adolescents admitted for substance use disorder treatment in the northeastern United States: comparison with a national survey. Subst Abus. 2013; 34: 263-272.
23. Mark TL, Song X, Vandivort R, et al. Characterizing substance abuse programs that treat adolescents. J Subst Abuse Treat. 2006; 31: 59-65.
24. Olmstead T, Sindelar JL. To what extent are key services offered in treatment programs for special populations J Subst Abuse Treat. 2004; 27: 9-15.
25. Substance Abuse and Mental Health Services Administration (SAMHSA). National Survey of Substance Abuse Treatment Services (N-SSATS): 2003. Data on Substance Abuse Treatment Facilities. Rockville, MD: SAMHSA; 2004.
26. Knudsen HK. Adolescent-only substance abuse treatment: availability and adoption of components of quality. J Subst Abuse Treat. 2009; 36: 195-204.
27. Hser YI, Grella CE, Hubbard RL, et al. An Evaluation of drug treatments for adolescents in 4 US cities. Arch Gen Psychiatry. 2001; 58: 689-695.
28. Center for Substance Abuse Treatment. Treatment of Adolescents With Substance Abuse Disorders. Rockville, MD: SAMHSA; 1999. CSAT Treatment Improvement Protocol Series, No. 32. DHHS Publication No. SMA 99-3283.
29. Chan Y, Dennis ML, Funk RR. Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment. J Subst Abuse Treat. 2008; 34: 14-24.
30. Esposito-Smythers C, Walsh A, Spirito A, Rizzo C, Goldston DB, Kaminer Y. Working with the suicidal client who also abuses substances. Cogn Behav Pract. 2012; 19: 245-255.
31. Aldrich H, Ruef M. Organizations Evolving. London: Sage; 2006.
32. Kaminer Y. Adolescent substance abuse treatment: evidence-based practice in outpatient services. Curr Psychiatry Rep. 2002; 4: 397-401.
33. The National Center on Addiction and Substance Abuse at Columbia University (CASA). Addiction Medicine: Closing the Gap Between Science and Practice. New York: CASA; 2012.
34. Fletcher AM. Inside Rehab. New York: Viking; 2013.
35. Roman PM, Blum TC. Athens, GA: National Treatment Center Study University of Georgia; 1998.
36. Kelly JF, Myers MG. Adolescents participation in Alcoholics Anonymous and Narcotics Anonymous: review, implications and future directions. J Psychoactive Drugs. 2007; 39: 259-269.
37. Winters KC. Treating adolescents with substance use disorders: an overview of practice issues and treatment outcome. Subst Abus. 1999; 20: 203-225.
38. Galanter M, Glickman L, Singer D. An overview of outpatient treatment of adolescent substance abuse. Subst Abus. 2007; 28: 51-58.
39. Kelly JF, Urbanoski K. Youth Recovery Contests: the incremental effects of 12-step attendance and involvement on adolescent outpatient outcomes. Alcohol Clin Exp Res. 2012; 36: 1219-1229.
40. Van Gundy K. Substance Abuse in Rural and Small Town America: A Carsey Institute Report on Rural America. Durham, NH: Carsey Institute, University of New Hampshire; 2006.
41. Zavela KJ, Battistich V, Gosselink CA, Dean BJ. Say Yes First: follow up of a five-year rural drug prevention program. J Drug Educ. 2004; 34: 73-88.
42. Young AM, Glover N, Havens JR. Rural adolescents' nonmedical prescription drug use: implications for intervention. Prev Res. 2012; 19: 7-9.
43. Pfeffer J, Salancik GR. The External Control of Organizations: A Resource Dependence Perspective. New York: Harper & Row; 1978.
44. Luft H, Robinson JC, Garnick D, Maerki S, McPhee S. The role of specialized clinical services in competition among hospitals. Inquiry. 1986; 23: 83-94.
45. Riggs PD. Treating adolescents for substance abuse and comorbid psychiatric disorders. Sci Pract Perspect. 2003; 2: 18-29.
46. Marsch LA, Bickel WK, Badger GJ, et al. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial. Arch Gen Psychiatry. 2005; 62: 1157-1164.
47. De Sousa A, De Sousa A. An open randomized trial comparing disulfiram and naltrexone in adolescents with alcohol dependence. J Subst Abuse. 2008; 13: 382-388.
48. Niederhofer H, Staffen W. Comparison of disulfiram and placebo in treatment of alcohol dependence of adolescents. Drug Alcohol Rev. 2003; 22: 295-297.
49. Clark DB, Wood DS, Cornelius JR, Bukstein OG, Martin CS. Clinical practices in the pharmacological treatment of comorbid psychopathology in adolescents with alcohol use disorders. J Subst Abuse Treat. 2003; 25: 293-295.
50. Deas D. Evidence-based treatments for alcohol use disorders in adolescents. Pediatrics. 2008; 121 (Suppl 4): S348-S354.
51. Matson SC, Hobson G, Abdel-Rasoul M, Bonny A. 5. Opiate abstinence among adolescents engaged in an outpatient buprenorphine clinic for the treatment of opiate dependence. J Adolesc Health. 2013; 52: S17.
52. Upadhyaya H, Deas D. Pharmacological interventions for adolescent substance use disorders. In: Kaminer Y, Bukstein OG., eds. Adolescent Substance Abuse: Psychiatric Comorbidity and High-Risk Behaviors. New York: Routledge/Taylor & Francis Group; 2008: 145-161.
53. Fiellin DA. Treatment of adolescent opioid dependence: no quick fix. JAMA. 2008; 300: 2057-2059.
54. Drug Strategies. Treating Teens: A Guide to Adolescent Drug Programs. Washington, DC: Drug Strategies; 2002.
55. Deas D, Riggs P, Langenbucher J, Goldman M, Brown S. Adolescents are not adults: developmental considerations in alcohol users. Alcohol Clin. Exp Res. 2000; 24: 232-237.
56. Kaminer Y, Slesnick N. Evidence-based cognitive-behavioral and family therapies for adolescent alcohol and other substance use disorders. Recent Dev Alcohol. 2005; 17: 383-405.
57. Mee-Lee DL, Gartner L, Miller MM, Shulman GD, Wilford BB. Patient Placement Criteria for the Treatment of Substance Related Disorders. 2nd ed. Chevy Chase, MD: American Society of Addiction Medicine; 1996.
58. Long JS, Freese J. Regression Models for Categorical Dependent Variables Using Stata. 2nd ed. College Station, TX: Stata Press; 2006.
59. Wood E, Samet JH, Volkow ND. Physician education in addiction medicine. JAMA. 2013; 310: 1673-1674.
60. Kelly KJ, Comello MLG, Edwards RW. Attitudes of rural middle-school youth toward alcohol, tobacco, drugs, and violence. Rural Educ. 2004; 25: 19-24.
61. Tai B, Straus MM, Liu D, Sparenborg S, Jackson R, McCarty D. The first decade of the national drug abuse treatment clinical trials network: bridging the gap between research and practice to improve drug abuse treatment. J Subst Abuse Treat. 2010; 38: S4-S13.
62. McCarty D, Gustafson D, Capoccia VA, Cotter F. Improving care for the treatment of alcohol and drug disorders. J Behav Health Serv Res. 2009; 36: 52-60.
63. Abraham AJ, Knudsen HK, Roman PM. A longitudinal examination of alcohol pharmacotherapy adoption in substance use disorder treatment programs: patterns of sustainability and discontinuation. J Stud Alcohol Drugs. 2011; 72: 669-677.
64. Knudsen HK, Abraham AJ, Oser CB. Barriers to the implementation of medication-assisted treatment for substance use disorders: the importance of funding policies and medical infrastructure. Eval. Program Plann. 2011; 34: 375-381.
65. Gordon AJ, Kavanagh G, Krumm M, et al. Facilitators and barriers in implementing buprenorphine in the Veterans Health Administration. Psychol Addict Behav. 2011; 25: 215-224.
66. Oliva EM, Maisel NC, Gordon AJ, Harris AH. Barriers to use of pharmacotherapy for addiction disorders and how to overcome them. Curr Psychiatry Rep. 2011; 13: 374-381.
67. Compton WM, Stein JB, Robertson EB, Pintello D, Pringle B, Volkow ND. Charting a course for health services research at the National Institute on Drug Abuse. J Subst Abuse Treat. 2005; 29: 167-172.
68. Carroll KM. Dissemination of evidence-based practices: how far we've come, and how much further we've got to go. Addiction. 2012; 107: 1031-1033.
69. Bradley KA, Kivlahan DR. Bringing patient-centered care to patients with alcohol use disorders. JAMA. 2014; 311: 1861-1862.